Conflict of Interest: Profits vs Safety Congressional Investigations US Senators Pharmaceutical industry holdings, 2004: http://www.consumerwatchdog.org/resources/SenPharma.pdf Oct 12: How Did the Vioxx Debacle Happen? USA Today / Lancet Oct 4: Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry Oct 3: BBC PANORAMA TONIGHT – Taken on Trust – 13 years-Medical…
Law Suits and Court Decisions Sep 15 2005: FDA Amicus Curiae–Kallas–claims FDA infallibility pre-empts state safety laws (warning: 1.6 MB file) Aug 6 2004: Psychiatrist Scolds the APA After Winning Distinguished Fellow Award/ NYC Sues 44 Pharma Companies Aug 5: Pfizer issues prosecutors a manual to defend drug – Star…
FDA Failed to Enforce Law Requiring Drugmakers to Disclose Test Data – WashPost Tue, 6 Jul 2004 A front page article in The Washington Post reports that the FDA failed to enforce the law that requires drug companies to disclose ALL clinical drug trials and ALL trial findings-whether they’re good…
NYS AG Expands Pharmaceutical probe – Forest Labs Wed, 30 Jun 2004 The New York Times reports (below) that New York State Attorney General, Eliot Spitzer, is broadening his legal investigation. “Mr. Spitzer said in a speech on Monday to health care lawyers that he would continue to investigate how…
Forest Labs Admits Concealment of data – Congressional Probe Expands Sat, 26 Jun 2004 New York Times business reporter, Barry Meier, reports, “Forest officials had not told a medical journal about a failed unpublished study in 2002 of Celexa use in children and adolescents, before the journal published an article…
Antidepressants – USA Today Editorial / AHRP OpEd/ WSJ Editorial Bashes Spitzer Mon, 21 Jun 2004 The debate about antidepressants, concealment of clinical trial data, and failure to warn about a suicide risk, is reaching an ever broader public. An editorial in USA Today and an invited Op Ed by…
NYS Attorney General files suit against GlaxoSmithKline for Concealing Drug Information Wed, 2 Jun 2004 The most positive development in the antidepressant drug saga is the filing of a much needed lawsuit by Eliot Spitzer, New York State Attorney General. The suit charges GlaxoSmithKline with having “engaged in repeated and…
Pfizer issues prosecutors a manual to defend drug – Star Ledger Thu, 5 Aug 2004 In the May 14, 2004, settlement of a lawsuit initiated by a whistleblower, Pfizer pleaded guilty to criminal fraud in the promotion of Neurontin, and agreed to pay $430 million. https://ahrp.org/infomail/04/05/16.php A report in The…
VIOXX – Merck–MEDCO – a case study Wed, 13 Oct 2004 Vioxx: A case study in how a lethal drug is marketed and dispensed – without MINIMAL safeguards to protect people’s lives. Merck marketed and sold billions of dollars worth of Vioxx through MEDCO–the largest Medicare Pharmacy Benefit Manager (PBM)…
Unlawful drug marketing: GlaxoSmithKline & 4,000 doctors Face Criminal Charges in Italy Mon, 7 Jun 2004 On March 25, 2004, the US Attorney in Pennsylvania commenced an investigation of Eli Lilly’s marketing promotion of Zyprexa (olanzapine), Prozac (fluoxetine) and Evista (raloxifene). On April 19, a class action lawsuit was filed…
Tue, 30 Nov 2004 Tonight the BBC- 2 is airing an investigative report about a series of drug experiments that were conducted on infants and children who were under the guardianship of the New York City Agency for Children’s Services (ACS), and living at Incarnation Children’s Center, a foster care…
TeenScreen – Angel of Mercy or Pill-Pusher for Drug Industry Thu, 14 Apr 2005 An investigative reporter has dug up the facts behind TeenScreen, the aggressive marketing scheme that targets America’s school children who are being “screened” for undetected mental problems – even though no accurate diagnostic screening tool for…
